ARCHIVES

NCI To Require Reports On Adverse Drug Reactions From Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 23 | June 10, 1994

Download PDF Visit The Full Archive

Related Articles

NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate

October 22, 1993

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

February 5, 2010

Drug Shortages: Institutions Report Halting Enrollment in Clinical Trials

March 22, 2013

Denman Hammond, NCCF Founder, Receives Award.

November 17, 2000

NCI director creates four new deputy director positions to manage the Institute.

February 20, 2004

UT-Houston Wins NIH Center Grant For Alternative Cancer Medicine Studies

November 3, 1995